Abstract
Aim:
Sirtuin 1 (Sirt1) is the class III histone/protein deacetylase that interferes with the NF-κB signaling pathway, thereby has anti-inflammatory function. This study was undertaken to investigate whether Sirt1 could protect osteoblasts against TNF-α-induced injury in vitro.
Methods:
Murine osteoblastic cell line, MC3T3-E1, was used. Overexpress of Sirt1 protein in MC3T3-E1 cells was made by transfection the cells with Sirt1-overexpressing adenovirus. The levels of mRNAs and proteins were determined with qRT-PCR and Western blotting, respectively. The activity of NF-κB was examined using NF-κB luciferase assay. The NO concentration was measured using the Griess method.
Results:
Treatment of MC3T3-E1 cells with TNF-α (2.5–10 ng/mL) suppressed Sirt1 protein expression in a concentration-dependent manner. TNF-α (5 ng/mL) resulted in an increase in apoptosis and a reduction in ALP activity in the cells. Overexpression of Sirt1 in the cells significantly attenuated TNF-α-induced injury through suppressing apoptosis, increasing ALP activity, and increasing the expression of Runx2 and osteocalcin mRNAs. Furthermore, overexpression of Sirt1 in the cells significantly suppressed TNF-α-induced NF-κB activation, followed by reducing the expression of iNOS and NO formation. Sirt1 activator resveratrol (10 μmol/L) mimicked the protection of the cells by Sirt1 overexpression against TNF-α-induced injury, which was reversed by the Sirt1 inhibitor EX-527 (5 μmol/L).
Conclusion:
Overexpression of Sirt1 protects MC3T3-E1 osteoblasts aganst TNF-α-induced cell injury in vitro, at least in part, via suppressing NF-κB signaling. Sirt1 may be a novel therapeutic target for treating rheumatoid arthritis-related bone loss.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Pacifici R . Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996; 11: 1043–51.
Romas E, Martin TJ . Cytokines in the pathogenesis of osteoporosis. Osteoporos Int 1997; 7: S47–53.
Angeli A, Dovio A, Sartori ML, Masera RG, Ceoloni B, Prolo P, et al. Interactions between glucocorticoids and cytokines in the bone microenvironment. Ann NY Acad Sci 2002; 996: 97–107.
Nowell MA, Richards PJ, Fielding CA, Ognjanovic S, Topley N, Williams AS, et al. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2006; 54: 2084–95.
Feldmann M, Brennan FM, Maini RN . Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397–440.
Pfeilschifter J, Köditz R, Pfohl M, Schatz H . Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002; 23: 90–119.
Scott DL, Kingsley GH . Tumor necrosis factor inhibitors for rheumatoid arthritis. New Engl J Med 2006; 355: 704–12.
Feldmann M, Maini RN . Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001; 19: 163–96.
Kuno H, Kurian SM, Hendy GN, White J, deLuca HF, Evans CO, et al. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Endocrinology 1994; 134: 2524–31.
Kitajima I, Soejima Y, Takasaki I, Beppu H, Tokioka T, Maruyama I . Ceramide-induced nuclear translocation of NF-kappa B is a potential mediator of the apoptotic response to TNF-alpha in murine clonal osteoblasts. Bone 1996; 19: 263–70.
Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J, et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 2000; 141: 3956–64.
Bäckesjö CM, Li Y, Lindgren U, Haldosén LA . Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J Bone Miner Res 2006; 21: 993–1002.
Haigis MC, Sinclair DA . Mammalian sirtuins: Biological insights and disease relevance. Annu Rev Pathol 2010; 5: 253–95.
Shakibaei M, Buhrmann C, Mobasheri A . Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-κB ligand (RANKL) activation of NF-κB signaling and inhibit osteoclastogenesis in bone-derived cells. J Biol Chem 2011; 286: 11492–505.
Chang J, Wang Z, Tang E, Fan Z, McCauley L, Franceschi R, et al. Inhibition of osteoblastic bone formation by nuclear factor-κB. Nat Med 2009; 15: 682–9.
Armour KE, van't Hof RJ, Grabowski PS, Reid DM, Ralston SH . Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis. J Bone Miner Res 1999; 14: 2137–42.
Chen RM, Chen TL, Chiu WT, Chang CC . Molecular mechanism of nitric oxide-induced osteoblast apoptosis. J Orthop Res 2005; 23: 462–8.
Lee JH, Song MY, Song EY, Kim EK, Moon WS, Han MK, et al. Overexpression of sirt1 protects pancreatic β-cells against cytokine toxicity by suppressing the nuclear factor-κB signaling pathway. Diabetes 2009; 58: 344–51.
Moncada S, Higgs A . The L-arginine nitric oxide pathway. N Engl J Med 1993; 329: 2002–12.
MacPherson H, Noble BS, Ralston SH . Expression and functional role of nitric oxide synthase isoforms in human osteoblast-like cells. Bone 1999; 24: 179–85.
Yang SR, Wright J, Bauter M, Seweryniak K, Kode A, Rahman I . Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-κB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol 2007; 292: L567–6.
Takayama K, Ishida K, Matsushita T, Fujita N, Hayashi S, Sasaki K, et al. Sirt1 regulation of apoptosis of human chondrocytes. Arthritis Rheum 2009; 60: 2731–40.
Zhang HN, Li L, Gao P, Chen HZ, Zhang R, Wei YS, et al. Involvement of the p65/RelA subunit of NF-kappaB in TNF-alpha-induced Sirt1 expression in vascular smooth muscle cells. Biochem Biophys Res Commun 2010; 397: 569–75.
Ammann P, Rizzoli R, Bonjour JP, Bourrin S, Meyer JM, Vassalli P, et al. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest 1997; 99: 1699–703.
Kimble RB, Bain S, Pacifici R . The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 1997; 12: 935–41.
Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M . Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989; 2: 244–7.
Redlich K, Hayer S, Maier A, Dunstan CR, Tohidast-Akrad M, Lang S, et al. Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum 2002; 46: 785–92.
Aggarwal BB . Tumor necrosis factors receptor associated signaling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Ann Rheum Dis 2000; 59: 6–16.
Chen G, Goeddel DV . TNF-R1 signaling: a beautiful pathway. Science 2002; 296: 1634–5.
Mukai T, Otsuka F, Otani H, Yamashita M, Takasugi K, Inagaki K, et al. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem Biophys Res Commun 2007; 356: 1004–10.
Wajant H, Pfizenmaier K, Scheurich P . Tumor necrosis factor signaling. Cell Death Differ 2003; 10: 45–65.
Kurokouchi K, Kambe F, Yasukawa K, Izumi R, Ishiguro N, Iwata H, et al. TNF-α increases expression of IL-6 and ICAM-1 genes through activation of NF-κB in osteoblast-like ROS17/2.8 cells. J Bone Miner Res 1998; 13: 1290–9.
Lee HL, Yi T, Woo KM, Ryoo HM, Kim GS, Baek JH . Msx2 mediates the inhibitory action of TNF-α on osteoblast differentiation. Exp Mol Med 2010; 42: 437–45.
Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369–80.
Salminen A, Kauppinen A, Suuronen T, Kaarniranta K . SIRT1 longevity factor suppresses NF-kappaB-driven immune responses: regulation of aging via NF-kappaB acetylation? Bioessays 2008; 30: 939–42.
Damoulis PD, Hauschka PV . Cytokines induce nitric oxide production in mouse osteoblasts. Biochem Biophys Res Commun 1994; 201: 924–31.
Saura M, Tarin C, Zaragoza C . Recent insights into the implication of nitric oxide in osteoblast differentiation and proliferation during bone development. Sci World J 2010; 10: 624–32.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, W., Shang, Wl., Wang, Hd. et al. Sirt1 overexpression protects murine osteoblasts against TNF-α-induced injury in vitro by suppressing the NF-κB signaling pathway. Acta Pharmacol Sin 33, 668–674 (2012). https://doi.org/10.1038/aps.2011.189
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2011.189
Keywords
This article is cited by
-
Sirtuins and Metabolism Biomarkers in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: a Correlation Study with Clinical Outcomes and Cognitive Impairments
Molecular Neurobiology (2024)
-
Glycyrrhizic Acid Protects Glomerular Podocytes Induced by High Glucose by Modulating SNARK/AMPK Signaling Pathway
Current Medical Science (2023)
-
Pinolenic acid exhibits anti-inflammatory and anti-atherogenic effects in peripheral blood-derived monocytes from patients with rheumatoid arthritis
Scientific Reports (2022)
-
Association of Serum Levels of Silent Information Regulator 1 with Persistent Organ Failure in Acute Pancreatitis
Digestive Diseases and Sciences (2019)
-
Chikusetsusaponin V Inhibits LPS-Activated Inflammatory Responses via SIRT1/NF-κB Signaling Pathway in RAW264.7 Cells
Inflammation (2018)
